CSC Launches eMEDlink® Telemedicine Solution

CSCCSC (NYSE: CSC) today launched CSC eMEDlink®, a pioneering telemedicine platform that enables clinicians in primary and secondary care to conduct secure, remote audio/visual consultations, and empower patients to take control of their personal care. Following a successful pilot at Frederiksberg Hospital in Copenhagen, Denmark, CSC is now taking the solution to the wider European and global market by starting a pilot at a hospital trust in the United Kingdom, where eMEDlink® will initially be rolled out to 25 patients with chronic obstructive pulmonary disease (COPD).

CSC eMEDlink® allows patients with long-term conditions (LTCs) and chronic diseases to be treated at home, receiving the same care and treatment as if they were admitted into the hospital. By following patients closely, with virtual ward rounds and ad hoc consultations, it helps reduce waiting times and costs associated with unplanned admissions, outpatient clinics and patient transport. Virtual monitoring also reduces the precedence of readmission following hospital discharge. CSC eMEDlink® has the capability to support the following conditions: COPD, asthma, diabetes, hypertension, mental health, obesity palliative care, post-operative care, pregnancy and stroke.

Patients using CSC eMEDlink® at home are provided with an easy to use modified wireless netbook that connects with different types of devices to monitor vital signs such as blood pressure or lung function. This allows them to capture their own readings, which are then communicated to clinicians to review and monitor their patients' conditions. The intelligent system creates alerts for patients' readings that exceed pre-determined thresholds, so that clinicians can take the appropriate action.

Among the European population, 30.9 percent have long-standing illnesses or health problems, with major and chronic diseases causing more than 86 percent of deaths in the EU(1). For example, research in the UK shows that long-term condition patients use disproportionately more primary and secondary care services - 52 percent of General Practitioner appointments, 65 percent of all outpatient appointments and 72 percent of all inpatient bed days(2).

CSC eMEDlink® increases patient access to speciality services, without the restrictions of physical distance. The reduced requirement to arrange transport and visit the hospital, allows for increased independence and quality of life, as patients can set and achieve goals around self-care, increasing proactive personal management of their condition and improving health outcomes. Patient confidentiality is also protected through secure storage of information including video consultations. Freddy Lykke, managing director, CSC European Healthcare Solution Centre, which developed the telemedicine platform, commented: "CSC eMEDlink® is a powerful solution in the way that it encompasses all three components of telemedicine: video consultation, the ability for patients to take their own measurements and the ability to present data back to patients, not only those provided by them but also all data held by medical providers. Combining this solution with other data means that telemedicine is not an isolated island. Very few telemedicine solutions on the market today offer such capability."

Another key benefit of CSC eMEDlink® is that it is a standard web-based software solution which is flexible, easy-to-use and offers excellent value. By reducing unplanned patient admission, hospitals will be able to make considerable savings when the cost of admitting a patient is about 3000 Euros.

Dr. Harald Deutsch, vice president, CSC Healthcare EMEA, concluded: "Aging is one of the greatest social and economic challenges of the 21st century for European societies. By 2025, more than 20 percent of Europeans will be 65 or older, with a rapid increase in the number over the age of 80. As a result, the percentage of people with LTCs is most likely increase. At a time when health budgets are restricted and governments want patients to have more choice and take control of their care, the use of telemedicine seems an obvious solution to many health challenges with which our societies are faced."

To arrange a demonstration on the CSC stand, please contact:
Susan Venables - Mobile: +44 7971 166936 This email address is being protected from spambots. You need JavaScript enabled to view it.

Related news articles:

  • CSC's Profile

About CSC Healthcare EMEA
CSC Healthcare EMEA is part of the CSC Global Healthcare Group, which serves both private and public sectors around the world. As a leading provider of interoperable, scalable IT healthcare solutions CSC is transforming healthcare with better information for better decisions. Working with health ministries and healthcare providers across the region CSC Healthcare EMEA helps to drive reform and rise to the challenge of delivering a digitised health service. Spearheading the development of its product range is the CSC European Solution Centre which is complemented by CSC's global Innovation Centres.

Currently the EMEA group has healthcare operations in more than 11 countries, employing approximately 3,000 healthcare experts. As part of a global group it is supported by an extensive partner network and provides substantial experience of national healthcare markets.

About CSC
CSC is a global leader in providing technology-enabled solutions and services through three primary lines of business. These include Business Solutions and Services, the Managed Services Sector and the North American Public Sector. CSC's advanced capabilities include system design and integration, information technology and business process outsourcing, applications software development, Web and application hosting, mission support and management consulting. The company has been recognized as a leader in the industry, including being named by FORTUNE Magazine as one of the World's Most Admired Companies for Information Technology Services (2011). Headquartered in Falls Church, Va., CSC has approximately 93,000 employees and reported revenue of $16.2 billion for the 12 months ended December 31, 2010. For more information, visit the company's website at www.csc.com.

1. Data from the European Union
2. UK Department of Health (2008)

Most Popular Now

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

Do Fitness Apps do More Harm than Good?

A study published in the British Journal of Health Psychology reveals the negative behavioral and psychological consequences of commercial fitness apps reported by users on social media. These impacts may...

AI Tool Beats Humans at Detecting Parasi…

Scientists at ARUP Laboratories have developed an artificial intelligence (AI) tool that detects intestinal parasites in stool samples more quickly and accurately than traditional methods, potentially transforming how labs diagnose...

Making Cancer Vaccines More Personal

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that...

AI, Health, and Health Care Today and To…

Artificial intelligence (AI) carries promise and uncertainty for clinicians, patients, and health systems. This JAMA Summit Report presents expert perspectives on the opportunities, risks, and challenges of AI in health...

AI can Better Predict Future Risk for He…

A landmark study led by University' experts has shown that artificial intelligence can better predict how doctors should treat patients following a heart attack. The study, conducted by an international...

AI System Finds Crucial Clues for Diagno…

Doctors often must make critical decisions in minutes, relying on incomplete information. While electronic health records contain vast amounts of patient data, much of it remains difficult to interpret quickly...

A New AI Model Improves the Prediction o…

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the...

Improved Cough-Detection Tech can Help w…

Researchers have improved the ability of wearable health devices to accurately detect when a patient is coughing, making it easier to monitor chronic health conditions and predict health risks such...

Multimodal AI Poised to Revolutionize Ca…

Although artificial intelligence (AI) has already shown promise in cardiovascular medicine, most existing tools analyze only one type of data - such as electrocardiograms or cardiac images - limiting their...

New AI Tool Makes Medical Imaging Proces…

When doctors analyze a medical scan of an organ or area in the body, each part of the image has to be assigned an anatomical label. If the brain is...